Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

0.00%

20.5¢ raptor resources limited

British journal of GPs ...pneumonia, page-27

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 27 Last

Share
Profile

Follow
trcb

258 Posts.

69

10/02/21

23:02

Post #: 50878148
Share

Originally posted by pilko3: ↑

We should remember that the Doctor at the Haberfield Clinic said that ResApdx actually diagnosed 5 cases of pneumonia that their doctors failed to diagnose. I bet tose patients are thankful for ResApdx yes? With all the negative comments from the naysayers and down rampers and even those who see themselves as being ultra knowlegable and fair posters these only post the reasons against RAP becoming a success...can't blame them for that actually there are many reasons no need to repeat them here.
There is a great deal of info out there that is so positive and that enhances RAP's credibility it gets hidden behind the negative posts. But these non holders keep posting their (half pie) in hindsight negative opinions which don't add anything to the threads apart from creating a nice buying opportunity. BOD? well that's another story and a major part of the current place we find ourselves in IMHO.
Five Pneumonia cases from ResApdx that their doctors failed to diagnose...how about that for apples? That is what ResApdx does...when the medical world and telehealth come of age then RAP will be right there in the front line IMHO. This is why I hold and accumulate...I am a believer in the tech and its unique respiratory disease diagnostic system.

Expand

That is good to hear regarding diagnosing where doctors did not if this can be expanded to a wider set thats great!

RAP Price at posting: 6.8¢ Sentiment: Sell Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

IRX

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

EEG

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

CLE

Cyclone signs MOU with Vale for development of Iron Bear play

HotCopper Highlights: Your most watched stocks for Week 46, 2024

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

BTH

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

CUF

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

BNL

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

GDM

Banshee's historic trenches prove rich in antimony and gold for GDM

First 27 Last

Add RAP (ASX) to my watchlist

British journal of GPs ...pneumonia, page-27

Top Stories

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play

Cyclone signs MOU with Vale for development of Iron Bear play

HotCopper Highlights: Your most watched stocks for Week 46, 2024

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch

Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks

Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado

Banshee's historic trenches prove rich in antimony and gold for GDM

Featured News